Increased Patient Role in Proposed Meaningful Use Stage II and III Recommendations

Perhaps one of the biggest changes in the proposed Meaningful Use Stage II and III recommendations is the increase in interactions with the patient as well as the documentation it entails. Some changes include:

30% of medication orders are to be tracked via an Electronic Medication Administration Record (EMAR)
Record 80% of patient demographics
Patient specific educational resources - Stage 1 requires this for 10% of patients, Stage 2 is unchanged, and Stage 3 expands this to 20% in common specific languages.

Patient education leaflets should help to improve the outcome of the patient as they continue their journey to recovery. Finding a patient education leaflet in a patients native language may seem like a daunting task, yet with Lexicomp you are guaranteed a trusted source of patient education pamphlets available in 19 of the most commonly used languages in U.S. and Canada. Another important feature is the ability to directly integrate Lexicomp's patient education materials into your HIS.